Company Accounts and Tax Online NI608507 Board of Directors 1.9.24 31.8.25 31.8.25 false iso4217:GBP xbrli:pure NI608507 2023-09-01 2024-08-31 NI608507 2025-08-31 NI608507 2024-09-01 2025-08-31 NI608507 2024-08-31 NI608507 countries:NorthernIreland 2024-09-01 2025-08-31 NI608507 curr:PoundSterling 2024-09-01 2025-08-31 NI608507 uk-bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 NI608507 uk-bus:Micro-entities 2024-09-01 2025-08-31 NI608507 uk-bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 NI608507 uk-bus:FullAccounts 2024-09-01 2025-08-31 NI608507 uk-bus:RegisteredOffice 2024-09-01 2025-08-31 NI608507 uk-bus:Director1 2024-09-01 2025-08-31 NI608507 uk-bus:Director1 2024-09-01 NI608507 uk-bus:Director1 2025-08-31 NI608507 uk-bus:CompanySecretary1 2024-09-01 2025-08-31 NI608507 core:AfterOneYear 2025-08-31 NI608507 core:AfterOneYear 2024-08-31 NI608507 core:WithinOneYear 2025-08-31 NI608507 core:WithinOneYear 2024-08-31 NI608507 core:WithinOneYear 2024-09-01 2025-08-31 NI608507 core:AfterOneYear 2025-08-31 NI608507 core:AfterOneYear 2024-08-31 NI608507 core:AfterOneYear 2024-09-01 2025-08-31 NI608507 core:ShareCapital 2025-08-31 NI608507 core:ShareCapital 2024-08-31 NI608507 core:RevaluationReserve 2025-08-31 NI608507 core:RevaluationReserve 2024-08-31 NI608507 core:RetainedEarningsAccumulatedLosses 2025-08-31 NI608507 core:RetainedEarningsAccumulatedLosses 2024-08-31 NI608507 1 2024-09-01 2025-08-31

# PHARMACON LIMITED

## Company Registration Number:
NI608507 (Northern Ireland)

## Unaudited micro entity accounts for the year ended 31 August 2025

## Period of accounts

## Start date: 01 September 2024

## End date: 31 August 2025

# PHARMACON LIMITED

## Contents of the Financial Statements

for the Period Ended 31 August 2025

Company Information - 3 |
Report of the Directors - 4 |
Profit and Loss Account - 5 |
Balance sheet - 6 |
Footnotes to the Balance Sheet - 8 |

# PHARMACON LIMITED

## Company Information

for the Period Ended 31 August 2025

Director: |  | Andrew Starkie
Secretary: |  | Andrew Starkie
Registered office: |  | 10 Kilvarragh Newry Co Down BT35 8XD
Company Registration Number: |  | NI608507 (Northern Ireland)

# PHARMACON LIMITED

## Directors' Report Period Ended 31 August 2025

The directors present their report with the financial statements of the company for the period ended 31 August 2025

Principal Activities

Pharmaceutical Consultants

Political and charitable donations

N/A

Company policy on the employment of disabled persons

The company policy is to employ disabled people whenever practical, no members of staff are registered disabled

Additional information

N/A

Directors

The directors shown below have held office during the whole of the period from 01 September 2024 to 31 August 2025
Andrew Starkie

Secretary
Andrew Starkie

This report was approved by the board of directors on 28 February 2026
And Signed On Behalf Of The Board By:

Name: Andrew Starkie
Status: Director

# PHARMACON LIMITED

## Profit and Loss Account

for the Period Ended 31 August 2025

| 2025 £ | 2024 £
--- | --- | ---
Turnover | 169,110 | 93,615
Income from coronavirus (COVID-19) business support grants | 0 | 0
Other Income | 0 | 0
Cost of Materials | ( 105,425 ) | ( 95,940 )
Staff Costs | ( 15,000 ) | ( 12,000 )
Depreciation and Writeoffs | ( 12,460 ) | ( 8,250 )
Other charges | ( 70,665 ) | ( 49,740 )
Tax on Profit | ( 0 ) | ( 0 )
Profit or (Loss) for Period | ( 34,440 ) | ( 72,315 )

# PHARMACON LIMITED

## Balance sheet

As at 31 August 2025

| 2025 £ | 2024 £
--- | --- | ---
Called up share capital not paid: | 0 | 0
Fixed Assets: | 29,650 | 20,650
Current assets: | 76,740 | 67,680
Prepayments and accrued income: | 0 | 0
Creditors: amounts falling due within one year: | ( 24,200 ) | ( 14,400 )
Net current assets (liabilities): | 52,540 | 53,280
Total assets less current liabilities: | 82,190 | 73,930
Creditors: amounts falling due after more than one year: | ( 50,400 ) | ( 28,200 )
Provision for liabilities: | ( 0 ) | ( 0 )
Accruals and deferred income: | ( 0 ) | ( 0 )
Total net assets (liabilities): | 31,790 | 45,730
Capital and reserves: | 31,790 | 45,730

# PHARMACON LIMITED

## Balance sheet continued

For the year ending 31 August 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 28 February 2026
And Signed On Behalf Of The Board By:

Name: Andrew Starkie
Status: Director

The notes form part of these financial statements

# PHARMACON LIMITED

## Footnotes to the Financial Statements

for the Period Ended 31 August 2025

- ## 1. Employee Information

  Average number of employees: 1

# PHARMACON LIMITED

## Footnotes to the Financial Statements

for the Period Ended 31 August 2025

- ## 2. Off balance sheet disclosure

  No